Skip to content
Loop Biz – Lifestyle
Author:
Akagera Medicines Inc
Akagera Medicines Reports Positive First-in-Human Data for Single-Ascending-Dose of AKG-100, Advancing a Potentially Transformative Long-Acting Therapeutic for Drug-Resistant Tuberculosis
July 20, 2026